Related Experiment Video

Updated: Aug 16, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Chlamydia pneumoniae and other risk factors for atherosclerosis

M Leinonen1

  • 1National Public Health Institute, Department in Oulu, FIN-90101 Oulu, Finland. maija.leinonen@ktl.fi

The Journal of Infectious Diseases
|June 6, 2000
PubMed

Insights

Chlamydia pneumoniae infections are linked to higher coronary heart disease (CHD) risk factors like smoking and altered lipid metabolism. This chronic infection may explain some known CHD risks, warranting further research into its mechanisms.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Cardiovascular Health

Background:

  • Seroepidemiologic studies investigate Chlamydia pneumoniae's role in coronary heart disease (CHD).
  • C. pneumoniae infections are more prevalent in smokers, suggesting a link between smoking and chronic infection.
  • Infections may influence lipid metabolism, a key factor in cardiovascular health.

Purpose of the Study:

  • To explore the association between Chlamydia pneumoniae infection and established coronary heart disease (CHD) risk factors.
  • To investigate how C. pneumoniae infection impacts lipid profiles and metabolic syndrome.
  • To determine if C. pneumoniae infection can partially explain existing CHD risk factors.

Main Methods:

  • Analysis of seroepidemiologic data to assess C. pneumoniae prevalence in relation to risk factors.
  • Comparison of lipid profiles (HDL, triglycerides) in patients with C. pneumoniae pneumonia versus other pneumonia types.
  • Examination of associations between chronic C. pneumoniae infection and lipid levels in a healthy population.

Main Results:

  • C. pneumoniae infections are more common in smokers.
  • Acute C. pneumoniae pneumonia is associated with lower HDL and higher triglyceride levels compared to other pneumonias.
  • Chronic C. pneumoniae infection correlates with elevated triglycerides and lowered HDL in healthy individuals.
  • Chronic C. pneumoniae infection significantly amplifies the CHD risk associated with metabolic syndrome.

Conclusions:

  • Chlamydia pneumoniae infection is associated with several classical coronary heart disease (CHD) risk factors.
  • The infection may contribute to altered lipid metabolism and enhance the impact of metabolic syndrome on CHD risk.
  • Further research is necessary to fully understand the pathogenetic mechanisms linking C. pneumoniae to CHD.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...